CN Patent

CN101534798B — 包含噻嗪类和血管紧张素ⅱ受体阻断剂的控释药物组合物

Assigned to Hanall Pharmaceutical Co Ltd · Expires 2012-02-15 · 14y expired

What this patent protects

本发明公开了包含噻嗪类化合物和血管紧张素II受体阻断剂的药物组合物及其配制技术。更特别地，本发明公开了噻嗪类化合物和血管紧张素II受体阻断剂的药物组合制剂，与同时给药所述药物的单组分制剂时相比，所述药物组合制剂使所述药物的药理学和临床抗高血压效应及并发症预防效应最大化并减少了所述药物的副作用。

USPTO Abstract

本发明公开了包含噻嗪类化合物和血管紧张素II受体阻断剂的药物组合物及其配制技术。更特别地，本发明公开了噻嗪类化合物和血管紧张素II受体阻断剂的药物组合制剂，与同时给药所述药物的单组分制剂时相比，所述药物组合制剂使所述药物的药理学和临床抗高血压效应及并发症预防效应最大化并减少了所述药物的副作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN101534798B
Jurisdiction
CN
Classification
—
Expires
2012-02-15
Drug substance claim
No
Drug product claim
No
Assignee
Hanall Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.